Method and apparatus for external stabilization of the heart valves and myocardium

• US 20060063970A1
• Filed: 06/17/2005
• Published: 03/23/2006
• Est. Priority Date: 09/06/2002
• Status: Abandoned Application

• Current Assignee: Mardil, Inc.
• Original Assignee: Mardil, Inc.
• Inventors: Raman, JaiShankar, Rao, P. Srirama
• Application Number:
  US11/156,004
• Publication Number:
  US 20060063970A1
• Time in Patent Office: Days
• US Class Current: 600/37
• CPC Class Codes: A61F 2/2481 Devices outside the heart wall, e.g. bags, strips or bands

Abstract

The present disclosure is directed to an external cardiac basal annuloplasty system (ECBAS or BACE-System: basal annuloplasty of the cardia externally) and methods for treatment of regurgitation of mitral and tricuspid valves. The BACE-System provides the ability to correct leakage of regurgitation of the valves with or without the use of cardiopulmonary bypass, particularly when the condition is related to dilation of the base of the heart. This ECBAS invention can be applied to the base of the heart epicardially, either to prevent further dilation or to actively reduce the size of the base of the heart. Such devices also include an extension thereto for the treatment of localized myocardial defects, scars and damage.

Claims

1. A device for use as an external heart stabilizer to provide both valvular stabilization and myocardial reinforcement, wherein the heart has a base and an apex, comprising:

(a) a strip of biocompatible, implantable material having a predetermined width adapted to encompass the base of the heart and not the apex of the heart to prevent basal dilation during all cardiac cycle phases; and

(b) an extension comprising a biocompatible, implantable material to provide mechanical myocardial reinforcement, wherein the extension is operably connected to the strip.

2. The device of claim 1, wherein in the biocompatible material facilitates cell ingrowth.

3. The device of claim 2, wherein the cells are stem cells or skeletal myoblast cells.

4. The device of claim 1, further comprising growth factors associated with the biocompatible material.

5. The device of claim 1, wherein the extension comprises a different material than the strip.

6. The device of claim 1, wherein the extension extends from the base of the heart towards the apex of the heart.

7. The device of claim 1, wherein the extension extends from the base of the heart, but does not reach the apex of the heart.

8. The device of claim 1, wherein the strip is a band that encircles the heart.

9. The device of claim 1, wherein substantially all parts of the strip are in continuous contact with heart tissue.

10. The device of claim 1, wherein the strip is constrictive during all parts of the cardiac cycle.

11. The device of claim 1, wherein the extension comprises a material that is more rigid relative to the strip.

12. The device of claim 1, wherein the strip and/or extension further comprises an inflatable bladder.

13. The device of claim 1, wherein the strip comprises a top edge, a bottom edge and a center portion, and wherein the extension is attached to the bottom edge.

14. The device of claim 13, wherein the extension is contiguous with the strip.

15. The device of claim 13, wherein the extension is narrower than the length of the strip.

16. The device of claim 13, wherein the distance from the top edge to the bottom edge is about 2 cm to 5 cm.

17. A method of treating a heart disease or disorder resulting in mitral and/or tricuspid valve regurgitation, comprising implanting a device of claim 1 in a subject afflicted with the disease or disorder, such that the device is located at the atrio-ventricular junction.

18. A method, comprising:

implanting the device of claim 1 along the atrio-ventricular junction of a subject, wherein the device reduces or eliminates mitral and/or tricuspid valve regurgitation in the subject.

19. A method of treating mitral and/or tricuspid valve regurgitation, comprising constricting the base of the heart at about the atrio-ventricular junction with a device located on the surface of the heart.

20. The method of claim 19, wherein the device comprises a biocompatible, implantable strip having a width of about 2 cm to 5 cm.

21. The method of claim 19, wherein the device is a band that encircles the heart.